Nuveen Asset Management Portfolio holdings
Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.
Top Buys
| 1 |
Merck
MRK
|
+$362M |
| 2 |
Prologis
PLD
|
+$358M |
| 3 |
NVIDIA
NVDA
|
+$305M |
| 4 |
Corteva
CTVA
|
+$235M |
| 5 |
Atlassian
TEAM
|
+$226M |
Top Sells
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.8B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$308M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$261M |
| 4 |
iShares Russell 1000 Growth ETF
IWF
|
+$259M |
| 5 |
Danaher
DHR
|
+$243M |
Sector Composition
| 1 | Technology | 22.57% |
| 2 | Healthcare | 14.16% |
| 3 | Financials | 12.95% |
| 4 | Consumer Discretionary | 9.77% |
| 5 | Industrials | 9.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1951
Asana
ASAN
$3.12B
| $4.4M | ﹤0.01% |
319,197
-162,542
| -34% | -$2.24M |
|
1952
BioXcel Therapeutics
BTAI
$49.8M
| $4.39M | ﹤0.01% |
12,775
-827
| -6% | -$284K |
|
1953
Hain Celestial
HAIN
$194M
| $4.39M | ﹤0.01% |
271,234
-18,292
| -6% | -$296K |
|
1954
Enovix
ENVX
$1.77B
| $4.38M | ﹤0.01% |
402,770
-705,629
| -64% | -$7.68M |
|
1955
Herbalife
HLF
$986M
| $4.38M | ﹤0.01% |
294,538
-47,346
| -14% | -$705K |
|
1956
AngioDynamics
ANGO
$433M
| $4.37M | ﹤0.01% |
317,475
+55,371
| +21% | +$763K |
|
1957
Montrose Environmental
MEG
$1.05B
| $4.36M | ﹤0.01% |
98,154
-2,828
| -3% | -$126K |
|
1958
Independent Bank Corp
IBCP
$657M
| $4.35M | ﹤0.01% |
181,915
-11,033
| -6% | -$264K |
|
|
PRVB
1959
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $4.35M | ﹤0.01% |
411,306
+29,409
| +8% | +$311K |
|
|
FNA
1960
DELISTED
Paragon 28, Inc.
FNA
| $4.33M | ﹤0.01% |
226,713
+65,267
| +40% | +$1.25M |
|
|
ACCD
1961
DELISTED
Accolade, Inc. Common Stock
ACCD
| $4.31M | ﹤0.01% |
553,565
+240,314
| +77% | +$1.87M |
|
1962
First Bancorp
FBNC
$2.29B
| $4.31M | ﹤0.01% |
100,632
-17,538
| -15% | -$751K |
|
|
PFC
1963
DELISTED
Premier Financial Corp. Common Stock
PFC
| $4.3M | ﹤0.01% |
159,490
-16,309
| -9% | -$440K |
|
1964
Stellar Bancorp
STEL
$1.61B
| $4.26M | ﹤0.01% |
+190,760
| New | +$4.26M |
|
1965
WideOpenWest
WOW
$442M
| $4.26M | ﹤0.01% |
467,527
-125,943
| -21% | -$1.15M |
|
1966
iShares MSCI South Korea ETF
EWY
$5.52B
| $4.24M | ﹤0.01% |
75,112
+24,480
| +48% | +$1.38M |
|
1967
Acushnet Holdings
GOLF
$4.38B
| $4.23M | ﹤0.01% |
99,672
-14,163
| -12% | -$601K |
|
1968
Vanda Pharmaceuticals
VNDA
$266M
| $4.23M | ﹤0.01% |
572,615
-506,276
| -47% | -$3.74M |
|
1969
Weis Markets
WMK
$1.75B
| $4.22M | ﹤0.01% |
51,257
-8,260
| -14% | -$680K |
|
1970
Urban Outfitters
URBN
$6.07B
| $4.21M | ﹤0.01% |
176,553
-77,610
| -31% | -$1.85M |
|
1971
Central Garden & Pet Class A
CENTA
$2.03B
| $4.21M | ﹤0.01% |
146,989
-31,372
| -18% | -$899K |
|
1972
XPeng
XPEV
$19.9B
| $4.21M | ﹤0.01% |
423,558
-699,973
| -62% | -$6.96M |
|
1973
Titan International
TWI
$552M
| $4.21M | ﹤0.01% |
274,537
+43,309
| +19% | +$664K |
|
1974
DocGo
DCGO
$150M
| $4.2M | ﹤0.01% |
594,476
-249,595
| -30% | -$1.76M |
|
|
EVOP
1975
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $4.2M | ﹤0.01% |
124,003
-24,793
| -17% | -$839K |
|